Nexgel, Inc.
NXGLW- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001468929
No open-market purchases or sales by Nexgel, Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $32.4K in total; no superinvestor holds it.
Other share classesNXGL
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 17, 2026, 2:20 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $3.00M (26.3% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | – | Jan 22, 2025 | Apr 1, 2024 | Mar 27, 2023 | Mar 21, 2022 |
| Revenue | $11.4M | $8.69M | $4.09M | $2.05M | $1.55M |
| Cost of revenue | $6.91M | $5.94M | $3.47M | $1.79M | $1.54M |
| Gross profit | $4.51M | $2.75M | $619.0K | $256.0K | $9.00K |
| Operating expenses | $7.86M | $6.30M | $4.10M | $3.60M | $2.58M |
| Research and development | $2.00K | $78.0K | $103.0K | $367.0K | $31.0K |
| Selling, general and administrative | $7.86M | $6.22M | $3.99M | $3.24M | $2.55M |
| Operating income | -$3.35M | -$3.55M | -$3.48M | -$3.35M | -$2.57M |
| Interest expense | – | – | $15.0K | – | – |
| Income tax | – | – | – | $0 | $0 |
| Net income | -$3.00M | -$3.28M | -$3.16M | -$4.75M | -$4.31M |
| EPS, basic | $-0.38 | $-0.50 | $-0.56 | $-0.85 | $-1.45 |
| EPS, diluted | $-0.38 | $-0.50 | $-0.56 | – | $-1.45 |
| Weighted shares, basic | 7.85M | 6.51M | 5.67M | 5.57M | 2.98M |
| Weighted shares, diluted | 7.85M | 6.51M | 5.67M | – | 2.98M |
| Margins and growth | |||||
| Gross margin | 39.5% | 31.6% | 15.1% | 12.5% | 0.6% |
| Operating margin | -29.3% | -40.9% | -85.0% | -163.5% | -165.7% |
| Net margin | -26.3% | -37.8% | -77.2% | -231.7% | -277.9% |
| Revenue growth, year over year | +31.5% | +112.5% | +99.7% | +32.0% | +130.1% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | – | Jan 22, 2025 | Apr 1, 2024 | Mar 27, 2023 | Mar 21, 2022 |
| Cash and equivalents | $317.0K | $1.81M | $2.70M | $1.10M | $13.3M |
| Short-term investments | – | – | – | $5.51M | – |
| Accounts receivable | $673.0K | $933.0K | $633.0K | $222.0K | $209.0K |
| Inventory | $2.11M | $1.75M | $1.32M | $502.0K | $291.0K |
| Total current assets | $4.34M | $5.11M | $5.05M | $7.50M | $13.9M |
| Property, plant and equipment | $1.96M | $2.21M | $1.50M | $721.0K | $723.0K |
| Goodwill | $1.13M | $1.13M | $1.13M | $311.0K | $311.0K |
| Intangible assets | $681.0K | $807.0K | $326.0K | $20.0K | $33.0K |
| Total assets | $10.5M | $11.0M | $9.96M | $10.4M | $17.0M |
| Accounts payable | – | – | $1.23M | $265.0K | $254.0K |
| Short-term debt | – | – | $245.0K | – | – |
| Total current liabilities | $2.96M | $2.47M | $2.55M | $859.0K | $2.89M |
| Long-term debt | $588.0K | $685.0K | $593.0K | $283.0K | – |
| Total liabilities | $5.57M | $4.90M | $4.79M | $2.72M | $4.90M |
| Shareholders' equity | $4.89M | $6.08M | $5.17M | $7.64M | $12.1M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | – | Jan 22, 2025 | Apr 1, 2024 | Mar 27, 2023 | Mar 21, 2022 |
| Operating cash flow | -$1.31M | -$3.87M | -$3.24M | -$2.99M | -$2.75M |
| Capital expenditures | $68.0K | $443.0K | $696.0K | $96.0K | $269.0K |
| Free cash flow | -$1.38M | -$4.31M | -$3.93M | -$3.09M | -$3.02M |
| Depreciation and amortization | $450.0K | $436.0K | $226.0K | $112.0K | $113.0K |
| Stock-based compensation | $654.0K | $367.0K | $217.0K | $298.0K | $285.0K |
| Investing cash flow | -$68.0K | -$775.0K | $4.46M | -$5.59M | -$269.0K |
| Financing cash flow | $630.0K | $3.75M | $379.0K | -$3.66M | $16.3M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 5.7% | 4.2% | 5.3% | 14.6% | 18.4% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 13, 2026 | 536.1K | −93.4% | SEC |
| Aug 14, 2026 | 9.75M | +20.8% | SEC |
| May 13, 2026 | 9.13M | +19.3% | SEC |
| Apr 28, 2026 | 8.85M | +15.6% | SEC |
| Mar 31, 2026 | 8.48M | +10.7% | SEC |
| Nov 12, 2025 | 8.14M | +19.9% | SEC |
| Aug 12, 2025 | 8.07M | +27.6% | SEC |
| May 13, 2025 | 7.65M | +22.9% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.